# rheumatology (blogs) — RSS Amplifier Recent posts from the 3 feeds in the RSS Amplifier directory that cover rheumatology. Page: Feed: --- ## [Stop Immunology-ing Cardiology](https://autoimmunedevreport.substack.com/p/stop-immunology-ing-cardiology) _2026-08-05 · Mike Putman · Autoimmune Drug Development Report_ Atherosclerosis may be inflammatory, but immunosuppression is not going to fix it ## [EBR Journal Club: Dapirolizumab Pegol in SLE (PHOENYCS GO)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-dapirolizumab-pegol) _2026-07-24 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast Episode 138 ## [NEJM Retracts Avacopan](https://autoimmunedevreport.substack.com/p/nejm-retracts-avacopan) _2026-07-02 · Mike Putman · Autoimmune Drug Development Report_ An unprecedented retraction reveals cracks in the very foundations of drug development ## [EBR Journal Club: Obexelimab in IgG4-Related Disease (INDIGO)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-obexelimab-in-igg4) _2026-06-29 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast, Episode 137 ## [EBR Journal Club: Secukinumab in Polymyalgia Rheumatica (REPLENISH)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-secukinumab-in-polymyalgia) _2026-06-15 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast Episode 136 ## [“Peptides,” BPC-157, and the Mainlining of Pseudoscientific Nonsense](https://autoimmunedevreport.substack.com/p/peptides-bpc-157-and-the-mainlining) _2026-06-04 · Mike Putman · Autoimmune Drug Development Report_ 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic ## [The (sc)Pen is Mightier Than the (iv)Cord](https://autoimmunedevreport.substack.com/p/the-scpen-is-mightier-than-the-ivcord) _2026-05-19 · Mike Putman · Autoimmune Drug Development Report_ SC anifrolumab hits the market ## [Re-Adjudicating Avacopan](https://autoimmunedevreport.substack.com/p/re-adjudicating-avacopan) _2026-05-05 · Mike Putman · Autoimmune Drug Development Report_ The FDA names names and moves to remove avacopan from the market ## [EBR Journal Club: Ixekizumab + Tirzepatide in Psoriatic Arthritis (TOGETHER-PsA)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-ixekizumab-tirzepatide) _2026-04-30 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast episode 135 ## [The CAR-T Landscape in Autoimmune Disease](https://autoimmunedevreport.substack.com/p/the-car-t-landscape-in-autoimmune) _2026-04-21 · Mike Putman · Autoimmune Drug Development Report_ Pipeline Monitor #2: AKA trying to get a handle on all this CAR-T madness ## [Non-Custodial Crypto Gateway (Sponsored)](https://crawlproof.com/a/9Jjn9VhDj3LU) _2026-04-21 · **Sponsored**_ Accept multi-chain crypto, automated fee handling, and trustless escrow with real-time settlement. ## [EBR Journal Club: Brepocitinib in Dermatomyositis (VALOR)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-brepocitinib-in) _2026-04-17 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast, Episode #134 ## [Critical Commentary: Run Fewer Phase 2 Trials](https://autoimmunedevreport.substack.com/p/stop-running-phase-2-trials) _2026-04-07 · Mike Putman · Autoimmune Drug Development Report_ Our most expensive ritual in drug development is mostly FDA-mandated(ish) theater. ## [Regulatory Breakdown: Nerandomilast for Progressive Pulmonary Fibrosis](https://autoimmunedevreport.substack.com/p/regulatory-breakdown-is-living-longer) _2026-03-24 · Mike Putman · Autoimmune Drug Development Report_ The surprising mortality benefit for Nerandomilast (Jascayd) in progressive pulmonary fibrosis ## [EBR Journal Club: Obinutuzumab in SLE (ALLEGORY)](https://autoimmunedevreport.substack.com/p/ebr-journal-club-obinutuzumab-in) _2026-03-19 · Mike Putman · Autoimmune Drug Development Report_ A companion to the Evidence Based Rheumatology podcast, Episode #133 ## [Regulatory Breakdown: Deucravacitinib (Sotyktu) for Psoriatic Arthritis](https://autoimmunedevreport.substack.com/p/regulatory-breakdown-deucravacitinib) _2026-03-09 · Mike Putman · Autoimmune Drug Development Report_ The Sixth Mechanism Arrives. Does Anyone Need It? ## [Critical Commentary: One Trial to Rule Them All](https://autoimmunedevreport.substack.com/p/critical-commentary-one-trial-to) _2026-03-09 · Mike Putman · Autoimmune Drug Development Report_ Unfortunately, there are no solutions in drug development, only trade offs ## [Pipeline Monitor: Avacopan Under Fire & B Cells are Having a Moment](https://autoimmunedevreport.substack.com/p/pipeline-monitor-b-cells-are-having) _2026-03-06 · Mike Putman · Autoimmune Drug Development Report_ But emerging indications for JAK/TYKs may be the story that lasts ## [Welcome to the Autoimmune Drug Development Report](https://autoimmunedevreport.substack.com/p/welcome-to-the-autoimmune-drug-development) _2026-03-05 · Mike Putman · Autoimmune Drug Development Report_ What's coming, what just landed, and where the industry is getting it wrong - a rheumatologist's take on autoimmune drug development. ## [Launching Superintelligent Medicine: A Substack on AI in Healthcare](https://paulsufka.com/launching-superintelligent-medicine-a-substack-on-ai-in-healthcare/) _2026-01-09 · Paul Sufka · Paul Sufka M.D._ I m excited to announce the launch of Superintelligent Medicine, a new Substack focused on the intersection of artificial intelligence and clinical medicine. My goal with Superintelligent Medicine is to share my insights on how to use AI tools effectively in clinical practice and your daily life. The first posts cover the widening gap between AI capability and physician adoption, and ... Read More ## [Unlimited Mobile Internet, One V-SIM (Sponsored)](https://crawlproof.com/a/o8rhjyufLjvH) _2026-01-09 · **Sponsored**_ Automatically switches across T-Mobile, AT&T and Verizon; no throttling, no contract. ## [The Current State of AI in Rheumatology — Virginia Society of Rheumatology 2025 Annual Meeting.](https://paulsufka.com/ai/) _2025-09-19 · Paul Sufka · Paul Sufka M.D._ Objectives Define the major types of artificial intelligence relevant to healthcare Describe current and emerging applications of AI in rheumatology Evaluate the limitations, ethical concerns, and future directions of AI integration in rheumatologic practice AI Basics Definitions hierarchy: Algorithms → Machine Learning → Deep Learning → Transformers → Large Language Models (LLMs) Transformers…